Cardiac Diagnostic Platform
Total Trials
9
As Lead Sponsor
7
As Collaborator
2
Total Enrollment
1,108
NCT05542732
Accuracy of CardioWatch 287-2 During Profound Hypoxia
Phase: N/A
Role: Lead Sponsor
Start: Jun 4, 2022
Completion: Jun 27, 2022
NCT05566886
Validation of a Vital Signs Monitoring Wristband
Start: Oct 19, 2022
Completion: Feb 7, 2023
NCT05899959
REmote CArdiac MOnitoring by the Corsano CardioWatch 287-2 Evaluation Study
Start: Jun 15, 2023
Completion: Dec 28, 2023
NCT06613958
Older Adults Exercising On Time
Role: Collaborator
Start: May 2, 2024
Completion: Jun 27, 2024
NCT06508619
Blood Pressure Treatment by the Corsano CardioWatch 287-2 Evaluation Study
Start: Jul 2, 2024
Completion: Aug 1, 2025
NCT06692374
Automated Cardiac Arrest Detection and Alerting in Daily Life
Start: Jan 1, 2025
Completion: Jan 1, 2028
NCT06955273
Multi-Centre Based Study Recognition of Atrial Fibrillation With the Corsano CardioWatch 287-2 System
Start: May 1, 2025
Completion: Jan 31, 2026
NCT06930833
FRAILTY Classification Algorithm for the Corsano CARDIOWATCH 287-2: a Development and Validation Study
Start: May 31, 2025
Completion: Oct 31, 2026
NCT06942338
Comparative Evaluation of Body Temperature Measurement Using the CardioWatch 287-2 in an Intensive Care Setting.
Completion: Sep 30, 2025
Loading map...